Literature DB >> 12217402

Association of the Src homology 2 domain-containing inositol 5' phosphatase (SHIP) to releasability in human basophils.

Susan M MacDonald1, Becky M Vonakis.   

Abstract

During the study of the biology of the Human recombinant Histamine Releasing Factor (HrHRF), we uncovered a hyperreleasable phenotype of basophils from HrHRF-responder donors. Basophils from these donors released histamne to HrHRF, IL-3 and D(2)O. While there has been a significant amount of work elucidating signal transduction events in human basophils, the reason for this hyperreleasable phenotype remained illusive. A clue to the releasability of these highly allergic, asthmatic HrHRF-responder donor basophils was demonstrated in studies using SHIP knockout mice. Bone marrow-derived mast cells from the SHIP knockout mice demonstrated hyperreleasability to stimuli through the IgE receptor and alteration of subsequent signal transduction events. We have demonstrated a highly significant negative correlation between the amount of SHIP protein per cell equivalent and maximum histamine release to HrHRF. These results provide a clue to the hyperreleasable phenotype and implicate SHIP as an additional regulator of secretion in human basophils.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217402     DOI: 10.1016/s0161-5890(02)00082-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung.

Authors:  Sun-Young Oh; Tao Zheng; Monica L Bailey; Dwayne L Barber; John T Schroeder; Yoon-Keun Kim; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2006-10-23       Impact factor: 10.793

Review 2.  Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Authors:  Peter Valent; Cem Akin; Patrizia Bonadonna; Karin Hartmann; Knut Brockow; Marek Niedoszytko; Boguslaw Nedoszytko; Frank Siebenhaar; Wolfgang R Sperr; Joanna N G Oude Elberink; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Andreas Reiter; Hanneke C Kluin-Nelemans; Olivier Hermine; Jason Gotlib; Sigurd Broesby-Olsen; Alberto Orfao; Hans-Peter Horny; Massimo Triggiani; Michel Arock; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol Pract       Date:  2019-02-05

Review 3.  The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria.

Authors:  Bingjing Zhou; Jie Li; Runqiu Liu; Lei Zhu; Cong Peng
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

4.  Role of SHIP-1 in the adaptive immune responses to aeroallergen in the airway.

Authors:  Sukit Roongapinun; Sun-Young Oh; Fan Wu; Ampai Panthong; Tao Zheng; Zhou Zhu
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.

Authors:  Niya Wanich; Anna Nowak-Wegrzyn; Hugh A Sampson; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

Review 6.  Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.

Authors:  Peter Valent; Cem Akin; Boguslaw Nedoszytko; Patrizia Bonadonna; Karin Hartmann; Marek Niedoszytko; Knut Brockow; Frank Siebenhaar; Massimo Triggiani; Michel Arock; Jan Romantowski; Aleksandra Górska; Lawrence B Schwartz; Dean D Metcalfe
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 7.  Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022.

Authors:  Peter Valent; Karin Hartmann; Patrizia Bonadonna; Marek Niedoszytko; Massimo Triggiani; Michel Arock; Knut Brockow
Journal:  Int Arch Allergy Immunol       Date:  2022-05-23       Impact factor: 3.767

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.